SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jon B. Toledo, Vivianna M. Van Deerlin, Edward B. Lee, EunRan Suh, Young Baek, John L. Robinson, Sharon X. Xie, Jennifer McBride, Elisabeth M. Wood, Theresa Schuck, David J. Irwin, Rachel G. Gross, Howard Hurtig, Leo McCluskey, Lauren Elman, Jason Karlawish, Gerard Schellenberg, Alice Chen-Plotkin, David Wolk, Murray Grossman, Steven E. Arnold, Leslie M. Shaw, Virginia M.-Y. Lee, John Q. Trojanowski, A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank, Alzheimer's & Dementia, 2014, 10, 4, 477

    CrossRef

  2. 2
    Dominique Bétemps, Jérémy Verchère, Sébastien Brot, Eric Morignat, Luc Bousset, Damien Gaillard, Latifa Lakhdar, Ronald Melki, Thierry Baron, Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA, Acta Neuropathologica Communications, 2014, 2, 1, 29

    CrossRef

  3. 3
    Amanda N. Sacino, Mieu Brooks, Michael A. Thomas, Alex B. McKinney, Nicholas H. McGarvey, Nicola J. Rutherford, Carolina Ceballos-Diaz, Janice Robertson, Todd E. Golde, Benoit I. Giasson, Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice, Acta Neuropathologica, 2014, 127, 5, 645

    CrossRef

  4. 4
    Andrew B. West, Rita M. Cowell, João P.L. Daher, Mark S. Moehle, Kelly M. Hinkle, Heather L. Melrose, David G. Standaert, Laura A. Volpicelli-Daley, Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents, Journal of Comparative Neurology, 2014, 522, 11
  5. 5
    L. A. Volpicelli-Daley, K. L. Gamble, C. E. Schultheiss, D. M. Riddle, A. B. West, V. M.- Y. Lee, Formation of  -synuclein Lewy neurite-like aggregates in axons impedes the transport of distinct endosomes, Molecular Biology of the Cell, 2014, 25, 25, 4010

    CrossRef

  6. 6
    Anne Vital, Wassillios G. Meissner, Marie-Hélène Canron, Marie-Laure Martin-Negrier, Erwan Bezard, François Tison, Claude Vital, Intra-axonal protein aggregation in the peripheral nervous system, Journal of the Peripheral Nervous System, 2014, 19, 1
  7. 7
    Gabor G. Kovacs, Leonid Breydo, Ryan Green, Viktor Kis, Gina Puska, Péter Lőrincz, Laura Perju-Dumbrava, Regina Giera, Walter Pirker, Mirjam Lutz, Ingolf Lachmann, Herbert Budka, Vladimir N. Uversky, Kinga Molnár, Lajos László, Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread, Neurobiology of Disease, 2014, 69, 76

    CrossRef

  8. 8
    Johannes Brettschneider, Kelly Del Tredici, David J. Irwin, Murray Grossman, John L. Robinson, Jon B. Toledo, Lubin Fang, Vivianna M. Van Deerlin, Albert C. Ludolph, Virginia M.-Y. Lee, Heiko Braak, John Q. Trojanowski, Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD), Acta Neuropathologica, 2014, 127, 3, 423

    CrossRef

  9. 9
    Johannes Brettschneider, Kimihito Arai, Kelly Del Tredici, Jon B. Toledo, John L. Robinson, Edward B. Lee, Satoshi Kuwabara, Kazumoto Shibuya, David J. Irwin, Lubin Fang, Vivianna M. Van Deerlin, Lauren Elman, Leo McCluskey, Albert C. Ludolph, Virginia M.-Y. Lee, Heiko Braak, John Q. Trojanowski, TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord, Acta Neuropathologica, 2014, 128, 3, 423

    CrossRef

  10. 10
    Adam L. Knight, Xiaohui Yan, Shusei Hamamichi, Rami R. Ajjuri, Joseph R. Mazzulli, Mike W. Zhang, J. Gavin Daigle, Siyuan Zhang, Akeem R. Borom, Lindsay R. Roberts, S. Kyle Lee, Susan M. DeLeon, Coralie Viollet-Djelassi, Dimitri Krainc, Janis M. O’Donnell, Kim A. Caldwell, Guy A. Caldwell, The Glycolytic Enzyme, GPI, Is a Functionally Conserved Modifier of Dopaminergic Neurodegeneration in Parkinson’s Models, Cell Metabolism, 2014, 20, 1, 145

    CrossRef

  11. 11
    Kurt A Jellinger, The pathomechanisms underlying Parkinson's disease, Expert Review of Neurotherapeutics, 2014, 14, 2, 199

    CrossRef

  12. 12
    Massimo S. Fiandaca, Howard J. Federoff, Using viral-mediated gene delivery to model Parkinson's disease: Do nonhuman primate investigations expand our understanding?, Experimental Neurology, 2014, 256, 117

    CrossRef

  13. 13
    JianGuo Zhong, PingLei Pan, ZhenYu Dai, HaiCun Shi, Voxelwise meta-analysis of gray matter abnormalities in dementia with Lewy bodies, European Journal of Radiology, 2014, 83, 10, 1870

    CrossRef

  14. 14
    Hien T. Tran, Charlotte Hiu-Yan Chung, Michiyo Iba, Bin Zhang, John Q. Trojanowski, Kelvin C. Luk, Virginia M.Y. Lee, α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration, Cell Reports, 2014, 7, 6, 2054

    CrossRef

  15. 15
    Robert E. Burke, Karen O'Malley, Axon degeneration in Parkinson's disease, Experimental Neurology, 2013, 246, 72

    CrossRef

  16. 16
    V. Annese, C. Barcia, F. Ros-Bernal, A. Gómez, C. M. Ros, V. De Pablos, E. Fernández-Villalba, M. E. De Stefano, M.-T. Herrero, Evidence of oligodendrogliosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism, Neuropathology and Applied Neurobiology, 2013, 39, 2
  17. 17
    Amanda N Sacino, Mieu Brooks, Nicholas H McGarvey, Alex B McKinney, Michael A Thomas, Yona Levites, Yong Ran, Todd E Golde, Benoit I Giasson, Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein, Acta Neuropathologica Communications, 2013, 1, 1, 38

    CrossRef

  18. 18
    David J. Irwin, John Q. Trojanowski, Many roads to Parkinson's disease neurodegeneration: Head trauma—A road more traveled than we know?, Movement Disorders, 2013, 28, 9
  19. 19
    David J. Irwin, Virginia M.-Y. Lee, John Q. Trojanowski, Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies, Nature Reviews Neuroscience, 2013, 14, 9, 626

    CrossRef

  20. 20
    J. Sun, N.J. Cairns, J.S. Perlmutter, R.H. Mach, J. Xu, Regulation of dopamine D3 receptor in the striatal regions and substantia nigra in diffuse Lewy body disease, Neuroscience, 2013, 248, 112

    CrossRef

  21. 21
    Johannes Brettschneider, Kelly Del Tredici, Jon B. Toledo, John L. Robinson, David J. Irwin, Murray Grossman, EunRan Suh, Vivianna M. Deerlin, Elisabeth M. Wood, Young Baek, Linda Kwong, Edward B. Lee, Lauren Elman, Leo McCluskey, Lubin Fang, Simone Feldengut, Albert C. Ludolph, Virginia M.-Y. Lee, Heiko Braak, John Q. Trojanowski, Stages of pTDP-43 pathology in amyotrophic lateral sclerosis, Annals of Neurology, 2013, 74, 1
  22. 22
    Gabor G. Kovacs, Uta Wagner, Benoit Dumont, Maria Pikkarainen, Awad A. Osman, Nathalie Streichenberger, Irene Leisser, Jérémy Verchère, Thierry Baron, Irina Alafuzoff, Herbert Budka, Armand Perret-Liaudet, Ingolf Lachmann, An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology, Acta Neuropathologica, 2012, 124, 1, 37

    CrossRef

  23. 23
    Kavita Prasad, Thomas G. Beach, John Hedreen, Eric K. Richfield, Critical Role of Truncated α-Synuclein and Aggregates in Parkinson's Disease and Incidental Lewy Body Disease, Brain Pathology, 2012, 22, 6
  24. 24
    Kelly Del Tredici, Heiko Braak, Lewy pathology and neurodegeneration in premotor Parkinson's disease, Movement Disorders, 2012, 27, 5
  25. 25
    George K. Tofaris, Lysosome-dependent pathways as a unifying theme in Parkinson's disease, Movement Disorders, 2012, 27, 11
  26. 26
    David J. Irwin, Matthew T. White, Jon B. Toledo, Sharon X. Xie, John L. Robinson, Vivianna Van Deerlin, Virginia M.-Y. Lee, James B. Leverenz, Thomas J. Montine, John E. Duda, Howard I. Hurtig, John Q. Trojanowski, Neuropathologic substrates of Parkinson disease dementia, Annals of Neurology, 2012, 72, 4
  27. 27
    S. J. Colloby, S. McParland, J. T. O'Brien, J. Attems, Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias, Brain, 2012, 135, 9, 2798

    CrossRef

  28. 28
    Kurt A. Jellinger, Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts, Movement Disorders, 2012, 27, 1
  29. 29
    Toshiro Kanazawa, Eijiro Adachi, Satoshi Orimo, Ayako Nakamura, Hidehiro Mizusawa, Toshiki Uchihara, Pale Neurites, Premature α-Synuclein Aggregates with Centripetal Extension from Axon Collaterals, Brain Pathology, 2012, 22, 1
  30. 30
    Sunil Patel, Edward B Lee, Sharon X Xie, Anica Law, Eric M Jackson, Steven E Arnold, Christopher M Clark, Leslie M Shaw, M Sean Grady, John Q Trojanowski, Roy H Hamilton, Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus, Fluids and Barriers of the CNS, 2012, 9, 1, 7

    CrossRef

  31. 31
    Kristen A. Malkus, Harry Ischiropoulos, Regional deficiencies in chaperone-mediated autophagy underlie α-synuclein aggregation and neurodegeneration, Neurobiology of Disease, 2012, 46, 3, 732

    CrossRef

  32. 32
    Kurt Jellinger, The role of α-synuclein in neurodegeneration — An update, Translational Neuroscience, 2012, 3, 2

    CrossRef

  33. 33
    Coro Paisán-Ruiz, Abi Li, Susanne A. Schneider, Janice L. Holton, Robert Johnson, Desmond Kidd, Jeremy Chataway, Kailash P. Bhatia, Andrew J. Lees, John Hardy, Tamas Revesz, Henry Houlden, Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations, Neurobiology of Aging, 2012, 33, 4, 814

    CrossRef

  34. 34
    Jinxia Zhou, Melissa Broe, Yue Huang, John P. Anderson, Wei-Ping Gai, Elizabeth A. Milward, Michelle Porritt, David Howells, Andrew J. Hughes, Xiaomin Wang, Glenda M. Halliday, Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson’s disease, Acta Neuropathologica, 2011, 121, 6, 695

    CrossRef

  35. 35
    Elisa A. Waxman, Benoit I. Giasson, Characterization of kinases involved in the phosphorylation of aggregated α-synuclein, Journal of Neuroscience Research, 2011, 89, 2
  36. 36
    Joseph R. Mazzulli, You-Hai Xu, Ying Sun, Adam L. Knight, Pamela J. McLean, Guy A. Caldwell, Ellen Sidransky, Gregory A. Grabowski, Dimitri Krainc, Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies, Cell, 2011, 146, 1, 37

    CrossRef

  37. 37
    Jeffrey H. Kordower, Hemraj B. Dodiya, Adam M. Kordower, Brian Terpstra, Katrina Paumier, Lalitha Madhavan, Caryl Sortwell, Kathy Steece-Collier, Timothy J. Collier, Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat, Neurobiology of Disease, 2011, 43, 3, 552

    CrossRef

  38. 38
    Kurt A. Jellinger, Youmans Neurological Surgery, 2011,

    CrossRef

  39. 39
    Elisa A. Waxman, Benoit I. Giasson, A novel, high-efficiency cellular model of fibrillar α-synuclein inclusions and the examination of mutations that inhibit amyloid formation, Journal of Neurochemistry, 2010, 113, 2
  40. 40
    Karen A. Lewis, Arynn Yaeger, George N. DeMartino, Philip J. Thomas, Accelerated formation of α-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations, Journal of Bioenergetics and Biomembranes, 2010, 42, 1, 85

    CrossRef

  41. 41
    J. Tong, H. Wong, M. Guttman, L. C. Ang, L. S. Forno, M. Shimadzu, A. H. Rajput, M. D. Muenter, S. J. Kish, O. Hornykiewicz, Y. Furukawa, Brain  -synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation, Brain, 2010, 133, 1, 172

    CrossRef

  42. 42
    Hsiao-Chun Cheng, Christina M. Ulane, Robert E. Burke, Clinical progression in Parkinson disease and the neurobiology of axons, Annals of Neurology, 2010, 67, 6
  43. 43
    Roy Hamilton, Sunil Patel, Edward B. Lee, Eric M. Jackson, Joanna Lopinto, Steven E. Arnold, Christopher M. Clark, Anuj Basil, Leslie M. Shaw, Sharon X. Xie, M. Sean Grady, John Q. Trojanowski, Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology, Annals of Neurology, 2010, 68, 4
  44. 44
    Thomas G. Beach, Charles H. Adler, Lucia I. Sue, Linda Vedders, LihFen Lue, Charles L. White III, Haru Akiyama, John N. Caviness, Holly A. Shill, Marwan N. Sabbagh, Douglas G. Walker, Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders, Acta Neuropathologica, 2010, 119, 6, 689

    CrossRef

  45. 45
    Anthony C. Vernon, Clive Ballard, Michel Modo, Neuroimaging for Lewy body disease: Is the in vivo molecular imaging of α-synuclein neuropathology required and feasible?, Brain Research Reviews, 2010, 65, 1, 28

    CrossRef

  46. 46
    Steven E. Arnold, Edward B. Lee, Paul J. Moberg, Lauren Stutzbach, Hala Kazi, Li-Ying Han, Virginia M. Y. Lee, John Q. Trojanowski, Olfactory epithelium amyloid-β and paired helical filament-tau pathology in Alzheimer disease, Annals of Neurology, 2010, 67, 4
  47. 47
    John E. Duda, Olfactory system pathology as a model of Lewy neurodegenerative disease, Journal of the Neurological Sciences, 2010, 289, 1-2, 49

    CrossRef

  48. 48
    Anne-Laure J. Mougenot, Dominique Bétemps, Kevin N. Hogeveen, Gabor G. Kovacs, Latifa Chouaf-Lakhdar, Ollivier Milhavet, Sylvain Lehmann, Stéphane Legastelois, Jean-Jacques Pin, Thierry G. Baron, Production of a monoclonal antibody, against human α-synuclein, in a subpopulation of C57BL/6J mice, presenting a deletion of the α-synuclein locus, Journal of Neuroscience Methods, 2010, 192, 2, 268

    CrossRef

  49. 49
    Jason P. Covy, Wuxing Yuan, Elisa A. Waxman, Howard I. Hurtig, Vivianna M. Van Deerlin, Benoit I. Giasson, Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations, Movement Disorders, 2009, 24, 1
  50. 50
    Daniel Brooks, Glenda M. Halliday, Intralaminar nuclei of the thalamus in Lewy body diseases, Brain Research Bulletin, 2009, 78, 2-3, 97

    CrossRef

  51. 51
    Elisa A. Waxman, Jason P. Covy, Irene Bukh, Xiaojie Li, Ted M. Dawson, Benoit I. Giasson, Leucine-Rich Repeat Kinase 2 Expression Leads to Aggresome Formation That Is Not Associated With α-Synuclein Inclusions, Journal of Neuropathology and Experimental Neurology, 2009, 68, 7, 785

    CrossRef

  52. 52
    Yanping Li, Wencheng Liu, Tinmarla F Oo, Lei Wang, Yi Tang, Vernice Jackson-Lewis, Chun Zhou, Kindiya Geghman, Mikhail Bogdanov, Serge Przedborski, M Flint Beal, Robert E Burke, Chenjian Li, Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease, Nature Neuroscience, 2009, 12, 7, 826

    CrossRef

  53. 53
    Dennis W Dickson, Heiko Braak, John E Duda, Charles Duyckaerts, Thomas Gasser, Glenda M Halliday, John Hardy, James B Leverenz, Kelly Del Tredici, Zbigniew K Wszolek, Irene Litvan, Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria, The Lancet Neurology, 2009, 8, 12, 1150

    CrossRef

  54. 54
    Jeffrey H. Kordower, Patrik Brundin, Propagation of host disease to grafted neurons: Accumulating evidence, Experimental Neurology, 2009, 220, 2, 224

    CrossRef

  55. 55
    Leslie Crews, Igor Tsigelny, Makoto Hashimoto, Eliezer Masliah, Role of Synucleins in Alzheimer’s Disease, Neurotoxicity Research, 2009, 16, 3, 306

    CrossRef

  56. 56
    Michail E. Kalaitzakis, Ronald K. B. Pearce, The morbid anatomy of dementia in Parkinson’s disease, Acta Neuropathologica, 2009, 118, 5, 587

    CrossRef

  57. 57
    Thomas G. Beach, Charles H. Adler, LihFen Lue, Lucia I. Sue, Jyothi Bachalakuri, Jonette Henry-Watson, Jeanne Sasse, Sarah Boyer, Scophil Shirohi, Reed Brooks, Jennifer Eschbacher, Charles L. White, Haru Akiyama, John Caviness, Holly A. Shill, Donald J. Connor, Marwan N. Sabbagh, Douglas G. Walker, Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction, Acta Neuropathologica, 2009, 117, 6, 613

    CrossRef

  58. 58
    Richard Camicioli, Myrlene Gee, Thomas P. Bouchard, Nancy J. Fisher, Chris C. Hanstock, Derek J. Emery, W.R. Wayne Martin, Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism, Parkinsonism & Related Disorders, 2009, 15, 3, 187

    CrossRef

  59. 59
    Jennifer C. Hanson, Carol F. Lippa, Neurobiology of Dementia, 2009,

    CrossRef

  60. 60
    Kurt A. Jellinger, A critical reappraisal of current staging of Lewy-related pathology in human brain, Acta Neuropathologica, 2008, 116, 1, 1

    CrossRef

  61. 61
    Kelly Del Tredici, Heiko Braak, A not entirely benign procedure: progression of Parkinson’s disease, Acta Neuropathologica, 2008, 115, 4, 379

    CrossRef

  62. 62
    Elisa A. Waxman, John E. Duda, Benoit I. Giasson, Characterization of antibodies that selectively detect α-synuclein in pathological inclusions, Acta Neuropathologica, 2008, 116, 1, 37

    CrossRef

  63. 63
    Thomas G. Beach, Charles L. White, Ronald L. Hamilton, John E. Duda, Takeshi Iwatsubo, Dennis W. Dickson, James B. Leverenz, Federico Roncaroli, Manuel Buttini, Christa L. Hladik, Lucia I. Sue, Joseph V. Noorigian, Charles H. Adler, Evaluation of α-synuclein immunohistochemical methods used by invited experts, Acta Neuropathologica, 2008, 116, 3, 277

    CrossRef

  64. 64
    Kimiko Obi, Haruhiko Akiyama, Hiromi Kondo, Yoko Shimomura, Masato Hasegawa, Takeshi Iwatsubo, Yoshikuni Mizuno, Hideki Mochizuki, Relationship of phosphorylated α-synuclein and tau accumulation to Aβ deposition in the cerebral cortex of dementia with Lewy bodies, Experimental Neurology, 2008, 210, 2, 409

    CrossRef

  65. 65
    James B. Leverenz, Ronald Hamilton, Debby W. Tsuang, Aimee Schantz, Darcy Vavrek, Eric B. Larson, Walter A. Kukull, Oscar Lopez, Douglas Galasko, Eliezer Masliah, Jeffrey Kaye, Randall Woltjer, Christopher Clark, John Q. Trojanowski, Thomas J. Montine, RESEARCH ARTICLE: Empiric Refinement of the Pathologic Assessment of Lewy-Related Pathology in the Dementia Patient, Brain Pathology, 2008, 18, 2
  66. 66
    Elisa A. Waxman, Benoit I. Giasson, Specificity and Regulation of Casein Kinase-Mediated Phosphorylation of α-Synuclein, Journal of Neuropathology and Experimental Neurology, 2008, 67, 5, 402

    CrossRef

  67. 67
    Michail E. Kalaitzakis, Manuel B. Graeber, Stephen M. Gentleman, Ronald K. B. Pearce, Striatal β-Amyloid Deposition in Parkinson Disease With Dementia, Journal of Neuropathology and Experimental Neurology, 2008, 67, 2, 155

    CrossRef

  68. 68
    Fumiaki Mori, Kunikazu Tanji, Haixin Zhang, Akiyoshi Kakita, Hitoshi Takahashi, Koichi Wakabayashi, α-Synuclein pathology in the neostriatum in Parkinson’s disease, Acta Neuropathologica, 2008, 115, 4, 453

    CrossRef

  69. 69
    Andrei Surguchov, 2008,

    CrossRef

  70. 70
    James Lowe, Suzanne Mirra, Bradley Hyman, Dennis Dickson, Greenfield's Neuropathology Eighth Edition. 2 Volume Set and DVD, 2008,

    CrossRef

  71. 71
    James Lowe, Dementias, 2008,

    CrossRef

  72. 72
    Ranjita Betarbet, J. Timothy Greenamyre, Parkinson's Disease, 2008,

    CrossRef

  73. 73
    Cristina M. Bäckman, Lufei Shan, YaJun Zhang, Barry J. Hoffer, Andreas C. Tomac, Alterations in prodynorphin, proenkephalin, and GAD67 mRNA levels in the aged human putamen: Correlation with Parkinson's disease, Journal of Neuroscience Research, 2007, 85, 4
  74. 74
    Hanae Nakashima-Yasuda, Kunihiro Uryu, John Robinson, Sharon X. Xie, Howard Hurtig, John E. Duda, Steven E. Arnold, Andrew Siderowf, Murray Grossman, James B. Leverenz, Randy Woltjer, Oscar L. Lopez, Ronald Hamilton, Debby W. Tsuang, Douglas Galasko, Eliezer Masliah, Jeffrey Kaye, Christopher M. Clark, Thomas J. Montine, Virginia M. -Y. Lee, John Q. Trojanowski, Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases, Acta Neuropathologica, 2007, 114, 3, 221

    CrossRef

  75. 75
    Heiko Braak, Magdalena Sastre, Kelly Del Tredici, Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease, Acta Neuropathologica, 2007, 114, 3, 231

    CrossRef

  76. 76
    Kunihiro Uryu, Xiao-Han Chen, Dan Martinez, Kevin D. Browne, Victoria E. Johnson, David I. Graham, Virginia M.-Y. Lee, John Q. Trojanowski, Douglas H. Smith, Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans, Experimental Neurology, 2007, 208, 2, 185

    CrossRef

  77. 77
    Yoshio Tsuboi, Hirotake Uchikado, Dennis W. Dickson, Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology, Parkinsonism & Related Disorders, 2007, 13, S221

    CrossRef

  78. 78
    Leah R. Anderson, Ranjita Betarbet, Marla Gearing, Jeffrey Gulcher, Andrew A. Hicks, Kári Stefánsson, James J. Lah, Allan I. Levey, PARK10 Candidate RNF11 Is Expressed by Vulnerable Neurons and Localizes to Lewy Bodies in Parkinson Disease Brain, Journal of Neuropathology and Experimental Neurology, 2007, 66, 10, 955

    CrossRef

  79. 79
    Erin H. Norris, Kunihiro Uryu, Susan Leight, Benoit I. Giasson, John Q. Trojanowski, Virginia M.-Y. Lee, Pesticide Exposure Exacerbates α-Synucleinopathy in an A53T Transgenic Mouse Model, The American Journal of Pathology, 2007, 170, 2, 658

    CrossRef

  80. 80
    S. Zach, H. Bueler, B. Hengerer, F. Gillardon, Predominant Neuritic Pathology Induced by Viral Overexpression of α-Synuclein in Cell Culture, Cellular and Molecular Neurobiology, 2007, 27, 4, 505

    CrossRef

  81. 81
    Margaret A. Piggott, Clive G. Ballard, Elise Rowan, Clive Holmes, Ian G. McKeith, Evelyn Jaros, Robert H. Perry, Elaine K. Perry, Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline, Synapse, 2007, 61, 11
  82. 82
    Ian Mckeith, The Dementias 2, 2007,

    CrossRef

  83. 83
    Murat Emre, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  84. 84
    Benoit I. Giasson, Jason P. Covy, Nancy M. Bonini, Howard I. Hurtig, Matthew J. Farrer, John Q. Trojanowski, Vivianna M. Van Deerlin, Biochemical and pathological characterization of Lrrk2, Annals of Neurology, 2006, 59, 2
  85. 85
    Kurt A. Jellinger, Johannes Attems, Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?, Acta Neuropathologica, 2006, 112, 3, 253

    CrossRef

  86. 86
    James E. Galvin, Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson’s disease: a case for the selective vulnerability of the substantia nigra, Acta Neuropathologica, 2006, 112, 2, 115

    CrossRef

  87. 87
    Ranjita Betarbet, Rosa M. Canet-Aviles, Todd B. Sherer, Pier G. Mastroberardino, Chris McLendon, Jin-Ho Kim, Serena Lund, Hye-Mee Na, Georgia Taylor, Neil F. Bence, Ron Kopito, Byoung Boo Seo, Takao Yagi, Akemi Yagi, Gary Klinefelter, Mark R. Cookson, J. Timothy Greenamyre, Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin–proteasome system, Neurobiology of Disease, 2006, 22, 2, 404

    CrossRef

  88. 88
    C. W. Shults, Lewy bodies, Proceedings of the National Academy of Sciences, 2006, 103, 6, 1661

    CrossRef

  89. 89
    Subhojit Roy, Bin Zhang, Virginia M.-Y. Lee, John Q. Trojanowski, Axonal transport defects: a common theme in neurodegenerative diseases, Acta Neuropathologica, 2005, 109, 1, 5

    CrossRef

  90. 90
    Emma J. Burton, Ian G. McKeith, David J. Burn, John T. O'Brien, Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging, Movement Disorders, 2005, 20, 12
  91. 91
    J. Eric Ahlskog, Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease, Movement Disorders, 2005, 20, 3
  92. 92
    H. Takahashi, K. Wakabayashi, Controversy: Is Parkinson's disease a single disease entity? Yes, Parkinsonism & Related Disorders, 2005, 11, S31

    CrossRef

  93. 93
    Esther Dalfó, Manuel Portero-Otín, Victoria Ayala, Anna Martínez, Reinald Pamplona, Isidre Ferrer, Evidence of Oxidative Stress in the Neocortex in Incidental Lewy Body Disease, Journal of Neuropathology and Experimental Neurology, 2005, 64, 9, 816

    CrossRef

  94. 94
    Felix Geser, Gregor K. Wenning, Werner Poewe, Ian McKeith, How to diagnose dementia with Lewy bodies: State of the art, Movement Disorders, 2005, 20, S12
  95. 95
    Erin H. Norris, Benoit I. Giasson, Role of Oxidative Damage in Protein Aggregation Associated with Parkinson's Disease and Related Disorders, Antioxidants & Redox Signaling, 2005, 7, 5-6, 672

    CrossRef

  96. 96
    Eizo Iseki, Wami Marui, Ryoko Yamamoto, Takashi Togo, Omi Katsuse, Masanori Kato, Takeshi Iwatsubo, Kenji Kosaka, Heii Arai, The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies, Neuroscience Letters, 2005, 380, 1-2, 161

    CrossRef

  97. 97
    David J. Burn, Update on dementia with lewy bodies, Current Neurology and Neuroscience Reports, 2005, 5, 5, 339

    CrossRef

  98. 98
    Laura Parkkinen, Tarja Kauppinen, Tuula Pirttilä, Jaana M. Autere, Irina Alafuzoff, α-Synuclein pathology does not predict extrapyramidal symptoms or dementia, Annals of Neurology, 2005, 57, 1
  99. 99
    E. Dalfó, J. L. Albasanz, M. Martín, I. Ferrer, Abnormal Metabotropic Glutamate Receptor Expression and Signaling in the Cerebral Cortex in Diffuse Lewy Body Disease is Associated with Irregular α-Synuclein/Phospholipase C (PLCβ1) Interactions, Brain Pathology, 2004, 14, 4
  100. 100
    Keith D Coon, Travis Dunckley, Dietrich A Stephan, Biomarker identification in neurologic diseases: improving diagnostics and therapeutics, Expert Review of Molecular Diagnostics, 2004, 4, 3, 361

    CrossRef

  101. 101
    Ian McKeith, Jacobo Mintzer, Dag Aarsland, David Burn, Helen Chiu, Jiska Cohen-Mansfield, Dennis Dickson, Bruno Dubois, John E Duda, Howard Feldman, Serge Gauthier, Glenda Halliday, Brian Lawlor, Carol Lippa, Oscar L Lopez, João Carlos Machado, John O'Brien, Jeremy Playfer, Dementia with Lewy bodies, The Lancet Neurology, 2004, 3, 1, 19

    CrossRef

  102. 102
    I.G. McKeith, U.P. Mosimann, Dementia with Lewy bodies and Parkinson's disease, Parkinsonism & Related Disorders, 2004, 10, S15

    CrossRef

  103. 103
    Masaki Takao, Bernardino Ghetti, Hirotaka Yoshida, Pedro Piccardo, Yolanda Narain, Jill R. Murrell, Ruben Vidal, Bradley S. Glazier, Ross Jakes, Miho Tsutsui, Maria Grazia Spillantini, R. Anthony Crowther, Michel Goedert, Atsuo Koto, Early-onset Dementia with Lewy Bodies, Brain Pathology, 2004, 14, 2
  104. 104
    Kathleen S Montine, Joseph F Quinn, Jing Zhang, Joshua P Fessel, L.Jackson Roberts, Jason D Morrow, Thomas J Montine, Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases, Chemistry and Physics of Lipids, 2004, 128, 1-2, 117

    CrossRef

  105. 105
    Susan Totterdell, Diane Hanger, Gloria E Meredith, The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain, Brain Research, 2004, 1004, 1-2, 61

    CrossRef

  106. 106
    Erin H Norris, Benoit I Giasson, Virginia M.-Y Lee, Stem Cells in Development and Disease, 2004,

    CrossRef

  107. 107
    K Uryu, B.I Giasson, L Longhi, D Martinez, I Murray, V Conte, M Nakamura, K Saatman, K Talbot, T Horiguchi, T McIntosh, V.M.-Y Lee, J.Q Trojanowski, Age-dependent synuclein pathology following traumatic brain injury in mice, Experimental Neurology, 2003, 184, 1, 214

    CrossRef

  108. 108
    Diane D. Murphy, Bernard Ravina, Brain banking for neurodegenerative diseases, Current Opinion in Neurology, 2003, 16, 4, 459

    CrossRef

  109. 109
    JOHN E. DUDA, BENOIT I. GIASSON, VIRGINIA M-Y. LEE, JOHN Q. TROJANOWSKI, Is the Initial Insult in Parkinson's Disease and Dementia with Lewy Bodies a Neuritic Dystrophy?, Annals of the New York Academy of Sciences, 2003, 991, 1
  110. 110
    Kurt A. Jellinger, Neuropathological spectrum of synucleinopathies, Movement Disorders, 2003, 18, S6
  111. 111
    HARRY ISCHIROPOULOS, Oxidative Modifications of α-Synuclein, Annals of the New York Academy of Sciences, 2003, 991, 1
  112. 112
    Deepak M. Sampathu, Benoit I. Giasson, Aaron C. Pawlyk, John Q. Trojanowski, Virginia M.-Y. Lee, Ubiquitination of α-Synuclein Is Not Required for Formation of Pathological Inclusions in α-Synucleinopathies, The American Journal of Pathology, 2003, 163, 1, 91

    CrossRef

  113. 113
    Kurt A. Jellinger, α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study, Acta Neuropathologica, 2003, 106, 3, 191

    CrossRef

  114. 114
    Diane Murphy, Bernard Ravina, Current Opinion in Neurology, 2003, 16, 4, 459

    CrossRef

  115. 115
    Dennis W. Dickson, Misfolded, protease-resistant proteins in animal models and human neurodegenerative disease, Journal of Clinical Investigation, 2002, 110, 10, 1403

    CrossRef

  116. 116
    Dennis W. Dickson, Misfolded, protease-resistant proteins in animal models and human neurodegenerative disease, Journal of Clinical Investigation, 2002, 110, 10, 1403

    CrossRef

  117. 117
    Julie Lotharius, Patrik Brundin, Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein, Nature Reviews Neuroscience, 2002, 3, 12, 932

    CrossRef

  118. 118
    Dennis W. Dickson, Carolyn F. Orr, Neuropathology of Dementia in Parkinson's Disease,
  119. 119
    Heiko Braak, Kelly Del Tredici, Non-Dopaminergic Pathology of Parkinson's Disease,